{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:04:25Z","timestamp":1774947865394,"version":"3.50.1"},"reference-count":17,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Special Fund for the Development of Liyang City People\u2019s Hospital, Affiliated of Xuzhou Medical University","award":["ZX202412"],"award-info":[{"award-number":["ZX202412"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br. J. Hosp. Med. (Lond)"],"abstract":"<jats:p>Aims\/Background: Patients with acute ST-segment elevation myocardial infarction (STEMI) are at high risk of major adverse cardiovascular events (MACE) even after discharge, underscoring the need to identify reliable biomarkers. Therefore, this study aimed to investigate the predictive performance of serum monomeric C-reactive protein (mCRP) for MACE in patients with acute STEMI at one-year post-discharge. Methods: A retrospective analysis was conducted on 242 patients with acute STEMI who underwent emergency Percutaneous Coronary Intervention (PCI) in Liyang City People\u2019s Hospital between January 2021 and December 2023. Patients were divided into the MACE group (n = 58) and the non-MACE group (n = 184) based on major adverse cardiovascular events. Univariate and binary logistic regression analyses were performed to identify factors influencing MACE events in patients with acute STEMI treated with emergency PCI. Furthermore, predictive performance was assessed using receiver operating characteristic curve (ROC) analysis. Results: There were no statistically significant differences (p &gt; 0.05) between the groups in terms of age, gender, body mass index (BMI), smoking history, alcohol consumption history, history of hypertension, left ventricular end-diastolic diameter (LVEDD), total cholesterol (TC), triglycerides (TG), B-type natriuretic peptide (BNP), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and left ventricular end-diastolic volume (LVEDV). Comparisons of mCRP (within 24 hours of admission), left ventricular ejection fraction (LVEF), and cardiac troponin I (cTnI) showed statistically significant differences (p &lt; 0.05). Monomeric CRP demonstrated a positive correlation with cTnI levels (r = 0.196, p &lt; 0.05). Binary logistic regression analysis identified mCRP, LVEF, and cTnI levels as independent predictors of one-year post-discharge MACE in patients with acute STEMI (p &lt; 0.05). ROC analysis yielded an area under the curve of 0.840 for mCRP (standard error = 0.028; 95% CI, 0.785\u20130.896, p &lt; 0.001). At the Youden index of 0.50, mCRP demonstrated a sensitivity of 77.59%, and a specificity of 72.83%. Conclusion: Monomeric CRP exhibits superior predictive performance for MACE in acute STEMI patients at one-year post-discharge.<\/jats:p>","DOI":"10.31083\/bjhm51835","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:00:46Z","timestamp":1774944046000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictive Performance of Serum Monomeric C-Reactive Protein for Major Adverse Cardiovascular Events in Patients With Acute ST-Segment Elevation Myocardial Infarction at One-Year Post-Discharge: A Retrospective Cohort Study"],"prefix":"10.31083","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0063-900X","authenticated-orcid":true,"given":"Ye","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Liyang City People\u2019s Hospital, 213300 Liyang, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Liyang City People\u2019s Hospital, 213300 Liyang, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengya","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Liyang City People\u2019s Hospital, 213300 Liyang, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueyun","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Liyang City People\u2019s Hospital, 213300 Liyang, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyun","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Liyang City People\u2019s Hospital, 213300 Liyang, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Liyang City People\u2019s Hospital, 213300 Liyang, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022; 145: e153\u2013e639.","DOI":"10.1161\/CIR.0000000000001052"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Pastorello Y, Carare RO, Banescu C, Potempa L, Di Napoli M, Slevin M. Monomeric C-reactive protein: A novel biomarker predicting neurodegenerative disease and vascular dysfunction. Brain Pathology. 2023; 33: e13164.","DOI":"10.1111\/bpa.13164"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Ross R. Atherosclerosis\u2013an inflammatory disease. New England Journal of Medicine. 1999; 340: 115\u2013126.","DOI":"10.1056\/NEJM199901143400207"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Ajoolabady A, Pratico D, Lin L, Mantzoros CS, Bahijri S, Tuomilehto J, et al. Inflammation in atherosclerosis: pathophysiology and mechanisms. Cell Death & Disease. 2024; 15: 817.","DOI":"10.1038\/s41419-024-07166-8"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Eisenhardt SU, Habersberger J, Murphy A, Chen YC, Woollard KJ, Bassler N, et al. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circulation Research. 2009; 105: 128\u2013137.","DOI":"10.1161\/CIRCRESAHA.108.190611"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Wu KL, Liang QH, Huang BT, Ding N, Li BW, Hao J. The plasma level of mCRP is linked to cardiovascular disease in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Research & Therapy. 2020; 22: 228.","DOI":"10.1186\/s13075-020-02321-w"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Zeller J, Bogner B, Kiefer J, Braig D, Winninger O, Fricke M, et al. CRP Enhances the Innate Killing Mechanisms Phagocytosis and ROS Formation in a Conformation and Complement-Dependent Manner. Frontiers in Immunology. 2021; 12: 721887.","DOI":"10.3389\/fimmu.2021.721887"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zhang L, Li HY, Li W, Shen ZY, Wang YD, Ji SR, et al. An ELISA Assay for Quantifying Monomeric C-Reactive Protein in Plasma. Frontiers in Immunology. 2018; 9: 511.","DOI":"10.3389\/fimmu.2018.00511"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Fujita C, Sakurai Y, Yasuda Y, Homma R, Huang CL, Fujita M. mCRP as a Biomarker of Adult-Onset Still\u2019s Disease: Quantification of mCRP by ELISA. Frontiers in Immunology. 2022; 13: 938173.","DOI":"10.3389\/fimmu.2022.938173"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Wang J, Tang B, Liu X, Wu X, Wang H, Xu D, et al. Increased monomeric CRP levels in acute myocardial infarction: a possible new and specific biomarker for diagnosis and severity assessment of disease. Atherosclerosis. 2015; 239: 343\u2013349.","DOI":"10.1016\/j.atherosclerosis.2015.01.024"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Yang Y, Li X, Chen G, Xian Y, Zhang H, Wu Y, et al. Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial. JAMA. 2023; 330: 1534\u20131545.","DOI":"10.1001\/jama.2023.19524"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, et al. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025; 151: e771\u2013e862.","DOI":"10.1161\/CIR.0000000000001309"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145: e895\u2013e1032.","DOI":"10.1161\/CIR.0000000000001063"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology. 2018; 72: 2231\u20132264.","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Huang L, Zhang J, Huang Q, Cui R, Chen J. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system. BMC Cardiovascular Disorders. 2023; 23: 198.","DOI":"10.1186\/s12872-023-03214-x"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Oemrawsingh RM, Akkerhuis KM, de Mulder M, Umans VA, Kietselaer B, Schotborgh C, et al. High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome. Circulation. 2019; 139: 134\u2013136.","DOI":"10.1161\/CIRCULATIONAHA.118.036349"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Fujita M, Takada YK, Izumiya Y, Takada Y. The binding of monomeric C-reactive protein (mCRP) to Integrins \u03b1v\u03b23 and \u03b14\u03b21 is related to its pro-inflammatory action. PLoS ONE. 2014; 9: e93738.","DOI":"10.1371\/journal.pone.0093738"}],"container-title":["British Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/3\/10.31083\/BJHM51835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:01:43Z","timestamp":1774944103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/3\/10.31083\/BJHM51835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1750-8460(26)02429-0"],"URL":"https:\/\/doi.org\/10.31083\/bjhm51835","relation":{},"ISSN":["1750-8460","1759-7390"],"issn-type":[{"value":"1750-8460","type":"print"},{"value":"1759-7390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"article-number":"51835"}}